4/A
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-20-060790
Chief Medical Officer sold 17,500 shares at $18.07 ($316,157)
- Chief Medical Officer acquired 12,235 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2018-11-15 | Option exercise | +12,235 | $5.28 | $64,601 | 195,625 | I: show line 1 in the form |
| Ho Carole Chief Medical Officer | 2018-11-15 | Sale | −17,500 | $18.07 | $316,157 | 178,125 | I: show line 2 in the form |
| Open-market sales · 17,500 sh · avg $18.07 · $316,157 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2018-11-15 | Option exercise · Stock Option (right to buy) | −12,235 | 101,875 | D: show line 3 in the form |
Loading xslF345X03/doc4a.xml…